Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome

NCT02940366 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome

Interventions

DRUG: Pitavastatin 4 mg orally daily
DRUG: Atorvastatin 20 mg orally daily

Sponsor

Seoul National University Hospital

Collaborators

[object Object]